When to measure plasma homocysteine and how to place it in context: The homocystinurias

1Fowler B. Homocysteine: overview of biochemistry, molecular biology, and role in disease processes. Semin Vasc Med. 2005;5(2):77–86. doi: 10.1055/s-2005-872394 Fowler B Homocysteine: overview of biochemistry, molecular biology, and role in disease processes Semin Vasc Med 20055277 86 10.1055/s-2005-87239416047261Open DOISearch in Google Scholar

2Froese DS, Fowler B, Baumgartner MR. Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673–85. doi: 10.1002/jimd.12009 Froese DS Fowler B Baumgartner MR Vitamin B12, folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation J Inherit Metab Dis 2019424673 85 10.1002/jimd.1200930693532Open DOISearch in Google Scholar

3Yap S, Naughten E. Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years’ experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis. 1998;21(7):738–47. doi: 10.1023/a:1005445132327 Yap S Naughten E Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years’ experience of a newborn screened and treated population with reference to clinical outcome and biochemical control J Inherit Metab Dis 1998217738 47 10.1023/a:1005445132327Open DOISearch in Google Scholar

4Morris AA, Kožich V, Santra S, Andria G, Ben-Omran TI, Chakrapani AB, et al. Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency. J Inherit Metab Dis. 2017;40(1):49–74. doi: 10.1007/s10545-016-9979-0 Morris AA Kožich V Santra S Andria G Ben-Omran TI Chakrapani AB et al Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency J Inherit Metab Dis 201740149 74 10.1007/s10545-016-9979-0520386127778219Open DOISearch in Google Scholar

5Huemer M, Diodato D, Martinelli D, Olivieri G, Blom H, Gleich F, et al. Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry. J Inherit Metab Dis. 2019;42(2):333–52. doi: 10.1002/jimd.12041 Huemer M Diodato D Martinelli D Olivieri G Blom H Gleich F et al Phenotype, treatment practice and outcome in the cobalamin-dependent remethylation disorders and MTHFR deficiency: Data from the E-HOD registry J Inherit Metab Dis 2019422333 52 10.1002/jimd.1204130773687Open DOISearch in Google Scholar

6Huemer M, Baumgartner MR. The clinical presentation of cobalamin-related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathways. J Inherit Metab Dis. 2019;42(4):686–705. doi: 10.1002/jimd.12012 Huemer M Baumgartner MR The clinical presentation of cobalamin-related disorders: From acquired deficiencies to inborn errors of absorption and intracellular pathways J Inherit Metab Dis 2019424686 705 10.1002/jimd.1201230761552Open DOISearch in Google Scholar

7Stabler SP. Clinical practice. Vitamin B12 deficiency. N Engl J Med. 2013;368(2):149–60. doi: 10.1056/NEJMcp1113996 Stabler SP Clinical practice. Vitamin B12 deficiency N Engl J Med 20133682149 60 10.1056/NEJMcp111399623301732Open DOISearch in Google Scholar

8Watkins D, Rosenblatt DS. Inborn errors of cobalamin absorption and metabolism. Am J Med Genet C Semin Med Genet. 2011;157C(1):33–44. doi: 10.1002/ajmg.c.30288 Watkins D Rosenblatt DS Inborn errors of cobalamin absorption and metabolism Am J Med Genet C Semin Med Genet 2011157C133–44 10.1002/ajmg.c.3028821312325Open DOISearch in Google Scholar

9Martinelli D, Deodato F, Dionisi-Vici C. Cobalamin C defect: natural history, pathophysiology, and treatment. J Inherit Metab Dis. 2011;34(1):127–35. doi: 10.1007/s10545-010-9161-z Martinelli D Deodato F Dionisi-Vici C Cobalamin C defect: natural history, pathophysiology, and treatment J Inherit Metab Dis 2011341127 35 10.1007/s10545-010-9161-z20632110Open DOISearch in Google Scholar

10Carrillo-Carrasco N, Chandler RJ, Venditti CP. Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis. 2012;35(1):91–102. doi: 10.1007/s10545-011-9364-y Carrillo-Carrasco N Chandler RJ Venditti CP Combined methylmalonic acidemia and homocystinuria, cblC type. I. Clinical presentations, diagnosis and management J Inherit Metab Dis 201235191 102 10.1007/s10545-011-9364-y421931821748409Open DOISearch in Google Scholar

11Rosenblatt DS, Aspler AL, Shevell MI, Pletcher BA, Fenton WA, Seashore MR. Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC). J Inherit Metab Dis. 1997;20(4):528–38. doi: 10.1023/a:1005353530303 Rosenblatt DS Aspler AL Shevell MI Pletcher BA Fenton WA Seashore MR Clinical heterogeneity and prognosis in combined methylmalonic aciduria and homocystinuria (cblC) J Inherit Metab Dis 1997204528 38 10.1023/a:1005353530303Open DOISearch in Google Scholar

12Acıpayam C, Güneş H, Güngör O, İpek S, Sarışık N, Demir NŞ. Cerebral atrophy in 21 hypotonic infants with severe vitamin B12 deficiency. J Paediatr Child Health. 2020;56(5):751–6. doi: 10.1111/jpc.14733 Acıpayam C Güneş H Güngör O İpek S Sarışık N Demir NŞ Cerebral atrophy in 21 hypotonic infants with severe vitamin B12 deficiency J Paediatr Child Health 2020565751 6 10.1111/jpc.1473331868292Open DOISearch in Google Scholar

13Roschitz B, Plecko B, Huemer M, Biebl A, Foerster H, Sperl W. Nutritional infantile vitamin B12 deficiency: pathobiochemical considerations in seven patients. Arch Dis Child Fetal Neonatal Ed. 2005;90(3):F281–2. doi: 10.1136/adc.2004.061929 Roschitz B Plecko B Huemer M Biebl A Foerster H Sperl W Nutritional infantile vitamin B12 deficiency: pathobiochemical considerations in seven patients Arch Dis Child Fetal Neonatal Ed 2005903F281 2 10.1136/adc.2004.061929172187815846026Open DOISearch in Google Scholar

14Fischer S, Huemer M, Baumgartner M, Deodato F, Ballhausen D, Boneh A, et al. Clinical presentation and outcome in a series of 88 patients with the cblC defect. J Inherit Metab Dis. 2014;37(5):831–40. doi: 10.1007/s10545-014-9687-6 Fischer S Huemer M Baumgartner M Deodato F Ballhausen D Boneh A et al Clinical presentation and outcome in a series of 88 patients with the cblC defect J Inherit Metab Dis 2014375831 40 10.1007/s10545-014-9687-624599607Open DOISearch in Google Scholar

15Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet. 1985;37(1):1–31. Mudd SH Skovby F Levy HL Pettigrew KD Wilcken B Pyeritz RE et al The natural history of homocystinuria due to cystathionine beta-synthase deficiency Am J Hum Genet 19853711 31Search in Google Scholar

16Al-Dewik N, Ali A, Mahmoud Y, Shahbeck N, Ali R, Mahmoud L, et al. Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population. J Inherit Metab Dis. 2019;42(5):818–30. doi: 10.1002/jimd.12099 Al-Dewik N Ali A Mahmoud Y Shahbeck N Ali R Mahmoud L et al Natural history, with clinical, biochemical, and molecular characterization of classical homocystinuria in the Qatari population J Inherit Metab Dis 2019425818 30 10.1002/jimd.1209930968424Open DOISearch in Google Scholar

17Huemer M, Diodato D, Schwahn B, Schiff M, Bandeira A, Benoist JF, et al. Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency. J Inherit Metab Dis. 2017;40(1):21–48. doi: 10.1007/s10545-016-9991-4 Huemer M Diodato D Schwahn B Schiff M Bandeira A Benoist JF et al Guidelines for diagnosis and management of the cobalamin-related remethylation disorders cblC, cblD, cblE, cblF, cblG, cblJ and MTHFR deficiency J Inherit Metab Dis 201740121 48 10.1007/s10545-016-9991-4520385927905001Open DOISearch in Google Scholar

18Burda P, Kuster A, Hjalmarson O, Suormala T, Bürer C, Lutz SR, et al. Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment. J Inherit Metab Dis. 2015;38(5):863–72. doi: 10.1007/s10545-015-9810-3 Burda P Kuster A Hjalmarson O Suormala T Bürer C Lutz SR et al Characterization and review of MTHFD1 deficiency: four new patients, cellular delineation and response to folic and folinic acid treatment J Inherit Metab Dis 2015385863 72 10.1007/s10545-015-9810-325633902Open DOISearch in Google Scholar

19Yu HC, Sloan JL, Scharer G, Brebner A, Quintana AM, Achilly NP, et al. An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1. Am J Hum Genet. 2013;93(3):506–14. doi: 10.1016/j.ajhg.2013.07.022 Yu HC Sloan JL Scharer G Brebner A Quintana AM Achilly NP et al An X-linked cobalamin disorder caused by mutations in transcriptional coregulator HCFC1 Am J Hum Genet 2013933506 14 10.1016/j.ajhg.2013.07.022376996824011988Open DOISearch in Google Scholar

20Quintana AM, Yu HC, Brebner A, Pupavac M, Geiger EA, Watson A, et al. Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities. Hum Mol Genet. 2017;26(15):2838–49. doi: 10.1093/hmg/ddx157 Quintana AM Yu HC Brebner A Pupavac M Geiger EA Watson A et al Mutations in THAP11 cause an inborn error of cobalamin metabolism and developmental abnormalities Hum Mol Genet 201726152838 49 10.1093/hmg/ddx157588623428449119Open DOISearch in Google Scholar

21Chien YH, Abdenur JE, Baronio F, Bannick AA, Corrales F, Couce M, et al. Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes. Orphanet J Rare Dis. 2015;10:99. doi: 10.1186/s13023-015-0321-y Chien YH Abdenur JE Baronio F Bannick AA Corrales F Couce M et al Mudd’s disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes Orphanet J Rare Dis 20151099 10.1186/s13023-015-0321-y454593026289392Open DOISearch in Google Scholar

22Barić I, Staufner C, Augoustides-Savvopoulou P, Chien YH, Dobbelaere D, Grünert SC, et al. Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders. J Inherit Metab Dis. 2017;40(1):5–20. doi: 10.1007/s10545-016-9972-7 Barić I Staufner C Augoustides-Savvopoulou P Chien YH Dobbelaere D Grünert SC et al Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders J Inherit Metab Dis 20174015 20 10.1007/s10545-016-9972-7Open DOISearch in Google Scholar

23Bublil EM, Majtan T. Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies. Biochimie. 2020;173:48–56. doi: 10.1016/j.biochi.2019.12.007 Bublil EM Majtan T Classical homocystinuria: from cystathionine beta-synthase deficiency to novel enzyme therapies Biochimie 202017348 56 10.1016/j.biochi.2019.12.007Open DOISearch in Google Scholar

24Diekman EF, de Koning TJ, Verhoeven-Duif NM, Rovers MM, van Hasselt PM. Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency. JAMA Neurol. 2014;71(2):188–94. doi: 10.1001/jamaneurol.2013.4915 Diekman EF de Koning TJ Verhoeven-Duif NM Rovers MM van Hasselt PM Survival and psychomotor development with early betaine treatment in patients with severe methylenetetrahydrofolate reductase deficiency JAMA Neurol 2014712188 94 10.1001/jamaneurol.2013.4915Open DOISearch in Google Scholar

25Keller R, Chrastina P, Pavlíková M, Gouveia S, Ribes A, Kölker S, et al.; individual contributors of the European Network and Registry for Homocystinurias and Methylation Defects (E-HOD), Barić I, Ben-Omran T, Blasco-Alonso J, Bueno Delgado MA, Carducci C, Cassanello M, et al. Newborn screening for homocystinurias: Recent recommendations versus current practice. J Inherit Metab Dis. 2019;42(1):128–39. doi: 10.1002/jimd.12034 Keller R Chrastina P Pavlíková M Gouveia S Ribes A Kölker S et al.; individual contributors of the European Network and Registry for Homocystinurias and Methylation Defects (E-HOD), Barić I, Ben-Omran T, Blasco-Alonso J, Bueno Delgado MA, Carducci C, Cassanello M, et al Newborn screening for homocystinurias: Recent recommendations versus current practice J Inherit Metab Dis 2019421128 39 10.1002/jimd.12034Open DOISearch in Google Scholar

26Huemer M, Kožich V, Rinaldo P, Baumgartner MR, Merinero B, Pasquini E, et al. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. J Inherit Metab Dis. 2015;38(6):1007–19. doi: 10.1007/s10545-015-9830-z Huemer M Kožich V Rinaldo P Baumgartner MR Merinero B Pasquini E et al Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines J Inherit Metab Dis 20153861007 19 10.1007/s10545-015-9830-zOpen DOISearch in Google Scholar

27Schif M, Blom HJ. Treatment of inherited homocystinurias. Neuropediatrics. 2012;43(6):295–304. doi: 10.1055/s-0032-1329883 Schif M Blom HJ Treatment of inherited homocystinurias Neuropediatrics 2012436295 304 10.1055/s-0032-1329883Open DOISearch in Google Scholar

28Andersson HC, Shapira E. Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC). J Pediatr. 1998;132(1):121–4. doi: 10.1016/s0022-3476(98)70496-2 Andersson HC Shapira E Biochemical and clinical response to hydroxocobalamin versus cyanocobalamin treatment in patients with methylmalonic acidemia and homocystinuria (cblC) J Pediatr 19981321121 4 10.1016/s0022-3476(98)70496-2Open DOISearch in Google Scholar

29Froese DS, Kopec J, Fitzpatrick F, Schuller M, McCorvie TJ, Chalk R, et al. Structural Insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking. J Biol Chem. 2015;290(49):29167–77. doi: 10.1074/jbc.M115.683268 Froese DS Kopec J Fitzpatrick F Schuller M McCorvie TJ Chalk R et al Structural Insights into the MMACHC-MMADHC protein complex involved in vitamin B12 trafficking J Biol Chem 20152904929167 77 10.1074/jbc.M115.683268470592326483544Open DOISearch in Google Scholar

30Erbe RW, Salis RJ. Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide – a cautionary tale. N Engl J Med. 2003;349(1):5–6. doi: 10.1056/NEJMp030093 Erbe RW Salis RJ Severe methylenetetrahydrofolate reductase deficiency, methionine synthase, and nitrous oxide – a cautionary tale N Engl J Med 200334915 6 10.1056/NEJMp03009312840086Open DOISearch in Google Scholar

31Selzer RR, Rosenblatt DS, Laxova R, Hogan K. Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency. N Engl J Med. 2003;349(1):45–50. doi: 10.1056/NEJMoa021867 Selzer RR Rosenblatt DS Laxova R Hogan K Adverse effect of nitrous oxide in a child with 5,10-methylenetetrahydrofolate reductase deficiency N Engl J Med 2003349145 50 10.1056/NEJMoa02186712840091Open DOISearch in Google Scholar

32Manoli I, Myles JG, Sloan JL, Carrillo-Carrasco N, Morava E, Strauss KA, et al. A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency. Genet Med. 2016;18(4):396–404. doi: 10.1038/gim.2015.107 Manoli I Myles JG Sloan JL Carrillo-Carrasco N Morava E Strauss KA et al A critical reappraisal of dietary practices in methylmalonic acidemia raises concerns about the safety of medical foods. Part 2: cobalamin C deficiency Genet Med 2016184396 404 10.1038/gim.2015.107475291226270766Open DOISearch in Google Scholar

33Weisfeld-Adams JD, Bender HA, Miley-Åkerstedt A, Frempong T, Schrager NL, Patel K, et al. Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type. Mol Genet Metab. 2013;110(3):241–7. doi: 10.1016/j.ymgme.2013.07.018 Weisfeld-Adams JD Bender HA Miley-Åkerstedt A Frempong T Schrager NL Patel K et al Neurologic and neurodevelopmental phenotypes in young children with early-treated combined methylmalonic acidemia and homocystinuria, cobalamin C type Mol Genet Metab 20131103241 7 10.1016/j.ymgme.2013.07.01823954310Open DOISearch in Google Scholar

34Matos IV, Castejón E, Meavilla S, O’Callaghan M, Garcia-Villoria J, López-Sala A, et al. Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency. Mol Genet Metab. 2013;109(4):360–5. doi: 10.1016/j.ymgme.2013.05.007 Matos IV Castejón E Meavilla S O’Callaghan M Garcia-Villoria J López-Sala A et al Clinical and biochemical outcome after hydroxocobalamin dose escalation in a series of patients with cobalamin C deficiency Mol Genet Metab 20131094360 5 10.1016/j.ymgme.2013.05.00723746552Open DOISearch in Google Scholar

35Trefz FK, Scheible D, Frauendienst-Egger G, Huemer M, Suomala T, Fowler B, et al. Successful intrauterine treatment of a patient with cobalamin C defect. Mol Genet Metab Rep. 2016;6:55–9. doi: 10.1016/j.ymgmr.2016.01.005 Trefz FK Scheible D Frauendienst-Egger G Huemer M Suomala T Fowler B et al Successful intrauterine treatment of a patient with cobalamin C defect Mol Genet Metab Rep 2016655 9 10.1016/j.ymgmr.2016.01.005478938527014578Open DOISearch in Google Scholar